tiprankstipranks
Swedish Orphan Biovitrum Ab (GB:0MTD)
:0MTD
UK Market
Holding GB:0MTD?
Track your performance easily

Swedish Orphan Biovitrum AB (0MTD) Income Statement

2 Followers

Swedish Orphan Biovitrum AB Income Statement

Last quarter (Q4 2022), Swedish Orphan Biovitrum AB's total revenue was $5.99B, an increase of 22.34% from the same quarter last year. In Q4, Swedish Orphan Biovitrum AB's net income was $1.39B. See Swedish Orphan Biovitrum AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 18.79B$ 18.79B$ 15.53B$ 15.26B$ 14.25B$ 9.14B
Cost of Revenue
$ 4.78B$ 4.78B$ 3.48B$ 3.23B$ 3.33B$ 2.42B
Gross Profit
$ 14.01B$ 14.01B$ 12.04B$ 12.04B$ 10.91B$ 6.72B
Operating Expense
$ 10.17B$ 10.17B$ 8.26B$ 7.57B$ 6.41B$ 3.60B
Operating Income
$ 3.85B$ 3.85B$ 3.79B$ 4.46B$ 4.50B$ 3.13B
Net Non Operating Interest Income Expense
$ -481.00M$ -481.00M$ -454.00M$ -486.00M$ -255.00M$ -56.00M
Other Income Expense
$ ―$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ 3.32B$ 3.32B$ 3.29B$ 4.22B$ 4.25B$ 3.08B
Tax Provision
$ 684.00M$ 683.00M$ 616.00M$ 972.00M$ 942.00M$ 664.00M
Earnings From Equity Interest Net Of Tax
$ ―$ ―$ ―$ ―$ ―$ ―
Net Income Common Stockholders
$ 2.64B$ 2.64B$ 2.68B$ 3.25B$ 3.30B$ 2.42B
Basic EPS
$ 7.07$ 8.92$ 9.08$ 11.01$ 11.29$ 8.97
Diluted EPS
$ 7.02$ 8.84$ 9.03$ 10.90$ 11.22$ 8.93
Basic Average Shares
$ 1.18B$ 295.60M$ 295.05M$ 294.66M$ 292.65M$ 269.52M
Diluted Average Shares
$ 1.19B$ 298.45M$ 296.80M$ 297.64M$ 294.53M$ 270.60M
Dividend Per Share
$ ―$ ―$ ―$ ―$ ―$ ―
Total Operating Income As Reported
$ ―$ ―$ ―$ ―$ ―$ ―
Reported Normalized Basic E P S
$ 9.88$ 10.77$ 9.08$ 9.66$ 11.89$ 8.97
Reported Normalized Diluted E P S
$ 9.79$ 10.66$ 9.03$ 9.56$ 11.81$ 8.93
Rent Expense Supplemental
$ ―$ ―$ ―$ ―$ 7.00M$ 87.00M
Total Expenses
$ 14.95B$ 14.95B$ 11.74B$ 10.80B$ 9.74B$ 6.01B
Net Income From Continuing And Discontinued Operation
$ 2.64B$ 2.64B$ 2.68B$ 3.25B$ 3.30B$ 2.42B
Normalized Income
$ 2.64B$ 2.64B$ 2.72B$ 2.94B$ 3.28B$ 2.42B
Interest Expense
$ 6.00M$ 458.00M$ 419.00M$ 454.00M$ 241.00M$ 56.00M
EBIT
$ 3.68B$ 3.78B$ 3.71B$ 4.67B$ 4.49B$ 3.14B
EBITDA
$ 6.10B$ 6.20B$ 5.72B$ 6.69B$ 6.08B$ 3.62B
Currency in USD

Swedish Orphan Biovitrum AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis